Clinical Trials and Emerging Therapies in Gestational Diabetes
Clinical trials for gestational diabetes mellitus (GDM) are exploring treatments like insulin sensitizers (e.g., metformin), GLP-1 receptor agonists, and lifestyle interventions to improve maternal glucose control. Emerging therapies also focus on personalized care strategies, early detection, and better fetal monitoring, aiming to reduce complications such as preterm birth and macrosomia. Advanced technologies, including continuous glucose monitoring (CGM) and telemedicine-based management, are enhancing real-time management and improving maternal and fetal outcomes.